{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:32:44Z","timestamp":1759451564059,"version":"build-2065373602"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00120-025-02674-7","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:48:08Z","timestamp":1757404088000},"page":"1055-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neues aus der Grundlagenforschung bei den Keimzelltumoren des Hodens und aktualisierte Tumorigenese","New insights from basic research on testicular germ cell tumors and updated tumorigenesis"],"prefix":"10.1007","volume":"64","author":[{"given":"Margaretha A.","family":"Skowron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Prokakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Fichtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Nestler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bremmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nettersheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/PAS.0000000000001865","volume":"46","author":"AM Acosta","year":"2022","unstructured":"Acosta\u00a0AM, Al-Obaidy\u00a0KI, Sholl\u00a0LM et\u00a0al (2022) Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors. Am J Surg Pathol 46:701\u2013712. https:\/\/doi.org\/10.1097\/PAS.0000000000001865","journal-title":"Am J Surg Pathol"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/HIS.15288","volume":"85","author":"AM Acosta","year":"2024","unstructured":"Acosta\u00a0AM, Berney\u00a0DM, Lobo\u00a0J et\u00a0al (2024) Proposal for a\u00a0reappraisal of the current classification of so-called \u201csomatic-type\u201d malignancies arising in germ cell tumours. Histopathology 85:743\u2013745. https:\/\/doi.org\/10.1111\/HIS.15288","journal-title":"Histopathology"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1097-0142(19850815)56:4<860::AID-CNCR2820560426>3.0.CO;2-3","volume":"56","author":"T Ahmed","year":"1985","unstructured":"Ahmed\u00a0T, Bosl\u00a0GJ, Hajdu\u00a0SI (1985) Teratoma with malignant transformation in germ cell tumors in men. Cancer 56:860\u2013863. https:\/\/doi.org\/10.1002\/1097-0142%2819850815%2956%3A4%E2%8C%A9860%3A%3Aaid-cncr2820560426%3E3.0.co%3B2-3","journal-title":"Cancer"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"a006151","DOI":"10.1101\/MCS.A006151\/-\/DC1","volume":"8","author":"H Alnajar","year":"2022","unstructured":"Alnajar\u00a0H, Ravichandran\u00a0H, Rendeiro\u00a0AF et\u00a0al (2022) Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a\u00a0metastatic sarcomatoid urothelial carcinoma with a\u00a0prolonged response to pembrolizumab. Cold Spring Harb Mol Case Stud 8:a6151. https:\/\/doi.org\/10.1101\/MCS.A006151","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"2674_CR5","doi-asserted-by":"publisher","first-page":"102356","DOI":"10.1016\/J.CLGC.2025.102356","volume":"23","author":"DR Bakaloudi","year":"2025","unstructured":"Bakaloudi\u00a0DR, Talukder\u00a0R, Enright\u00a0T et\u00a0al (2025) Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes. Clin Genitourin Cancer 23:102356. https:\/\/doi.org\/10.1016\/J.CLGC.2025.102356","journal-title":"Clin Genitourin Cancer"},{"key":"2674_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/HIS.14675","volume":"81","author":"DM Berney","year":"2022","unstructured":"Berney\u00a0DM, Cree\u00a0I, Rao\u00a0V et\u00a0al (2022) An introduction to the WHO 5th\u00a0edition 2022 classification of testicular tumours. Histopathology 81:459\u2013466. https:\/\/doi.org\/10.1111\/HIS.14675","journal-title":"Histopathology"},{"key":"2674_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/HIS.14933","volume":"83","author":"F Bremmer","year":"2023","unstructured":"Bremmer\u00a0F, Lubk\u00a0L, Str\u00f6bel\u00a0P, Nettersheim\u00a0D (2023) Updating germ cell tumour pathogenesis\u2014the ability of seminomas for FOXA2-driven extra-embryonic differentiation. Histopathology 83:477\u2013481. https:\/\/doi.org\/10.1111\/HIS.14933","journal-title":"Histopathology"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/S41416-023-02425-5","volume":"129","author":"F Bremmer","year":"2023","unstructured":"Bremmer\u00a0F, Pongratanakul\u00a0P, Skowron\u00a0M et\u00a0al (2023) Characterizing the mutational burden, DNA methylation landscape, and proteome of germ cell tumor-related somatic-type malignancies to identify the tissue-of-origin, mechanisms of therapy resistance, and druggable targets. Br J Cancer 129:1580\u20131589. https:\/\/doi.org\/10.1038\/S41416-023-02425-5","journal-title":"Br J Cancer"},{"key":"2674_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/10668969251343220","author":"B Chu","year":"2025","unstructured":"Chu\u00a0B, Huang\u00a0J (2025) Neuroendocrine Tumor as a\u00a0Somatic-Type Malignancy in Metastatic Teratoma. Int J Surg Pathol. https:\/\/doi.org\/10.1177\/10668969251343220","journal-title":"Int J Surg Pathol"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0022-5347(01)63754-6","volume":"159","author":"CV Comiter","year":"1998","unstructured":"Comiter\u00a0CV, Kibel\u00a0AS, Richie\u00a0JP et\u00a0al (1998) Prognostic features of teratomas with malignant transformation: A\u00a0clinicopathological study of 21 cases. J\u00a0Urol 159:859\u2013863. https:\/\/doi.org\/10.1016\/S0022-5347(01)63754-6","journal-title":"J Urol"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/ANDR.13751","volume":"13","author":"H Farahani","year":"2025","unstructured":"Farahani\u00a0H, Darvishvand\u00a0R, Khademolhosseini\u00a0A, Erfani\u00a0N (2025) Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies. Andrology 13:747\u2013762. https:\/\/doi.org\/10.1111\/ANDR.13751","journal-title":"Andrology"},{"key":"2674_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/HIS.14258","volume":"78","author":"A Fichtner","year":"2021","unstructured":"Fichtner\u00a0A, Richter\u00a0A, Filmar\u00a0S et\u00a0al (2021) The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reaction. Histopathology 78:593\u2013606. https:\/\/doi.org\/10.1111\/HIS.14258","journal-title":"Histopathology"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/IJC.35278","volume":"156","author":"AM Filho","year":"2024","unstructured":"Filho\u00a0AM, Laversanne\u00a0M, Ferlay\u00a0J et\u00a0al (2024) The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a\u00a0snapshot of the cancer burden worldwide. Int J Cancer 156:1336\u20131346. https:\/\/doi.org\/10.1002\/IJC.35278","journal-title":"Int J Cancer"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"102374","DOI":"10.1016\/J.CTRV.2022.102374","volume":"105","author":"M Fontes-Sousa","year":"2022","unstructured":"Fontes-Sousa\u00a0M, Calvo\u00a0E (2022) First-line immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma with sarcomatoid features. Cancer Treat Rev 105:102374. https:\/\/doi.org\/10.1016\/J.CTRV.2022.102374","journal-title":"Cancer Treat Rev"},{"key":"2674_CR15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi\u00a0L, Senovilla\u00a0L, Vitale\u00a0I et\u00a0al (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31:1869\u20131883. https:\/\/doi.org\/10.1038\/onc.2011.384","journal-title":"Oncogene"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/J.ACUROE.2014.09.002","volume":"38","author":"L Garc\u00eda-Labastida","year":"2014","unstructured":"Garc\u00eda-Labastida\u00a0L, G\u00f3mez-Mac\u00edas\u00a0GS, Flores-Guti\u00e9rrez\u00a0JP et\u00a0al (2014) Secondary malignant transformation of testicular teratomas: Case series and literature review. Actas Urol\u00f3gicas Espa\u00f1ola 38:622\u2013627. https:\/\/doi.org\/10.1016\/J.ACUROE.2014.09.002","journal-title":"Actas Urol\u00f3gicas Espa\u00f1ola"},{"key":"2674_CR17","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1200\/JCO.2021.39.15_SUPPL.4568","volume":"39","author":"D Gopalakrishnan","year":"2021","unstructured":"Gopalakrishnan\u00a0D, Collier\u00a0K, Park\u00a0JJ et\u00a0al (2021) Immune checkpoint inhibitors (ICI) in advanced sarcomatoid renal cell carcinoma (sRCC): A\u00a0multicenter study. JCO 39:4568\u20134568. https:\/\/doi.org\/10.1200\/JCO.2021.39.15_SUPPL.4568","journal-title":"JCO"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/CPHY.C110045","volume":"2","author":"D G\u00fcnzel","year":"2012","unstructured":"G\u00fcnzel\u00a0D, Fromm\u00a0M (2012) Claudins and other tight junction proteins. Compr Physiol 2:1819\u20131852. https:\/\/doi.org\/10.1002\/CPHY.C110045","journal-title":"Compr Physiol"},{"key":"2674_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/J.HUMPATH.2023.02.008","volume":"133","author":"CC Guo","year":"2023","unstructured":"Guo\u00a0CC, Czerniak\u00a0B (2023) Reprint of: somatic-type malignancies in testicular germ cell tumors. Hum Pathol 133:102\u2013114. https:\/\/doi.org\/10.1016\/J.HUMPATH.2023.02.008","journal-title":"Hum Pathol"},{"key":"2674_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1606639","author":"A Hanif","year":"2019","unstructured":"Hanif\u00a0A, Pandey\u00a0M, Khan\u00a0S et\u00a0al (2019) Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors. OncoImmunology. https:\/\/doi.org\/10.1080\/2162402X.2019.1606639","journal-title":"OncoImmunology"},{"key":"2674_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/J.UCL.2019.04.008","volume":"46","author":"A Hiester","year":"2019","unstructured":"Hiester\u00a0A, Nettersheim\u00a0D, Nini\u00a0A et\u00a0al (2019) Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome. Urol Clin N Am 46:419\u2013427. https:\/\/doi.org\/10.1016\/J.UCL.2019.04.008","journal-title":"Urol Clin N Am"},{"key":"2674_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAS.0000000000000322","volume":"39","author":"BE Howitt","year":"2015","unstructured":"Howitt\u00a0BE, Magers\u00a0MJ, Rice\u00a0KR et\u00a0al (2015) Many postchemotherapy sarcomatous tumors in patients with testicular germ cell tumors are sarcomatoid yolk sac tumors: A\u00a0study of 33\u00a0cases. Am J Surg Pathol 39:251\u2013259. https:\/\/doi.org\/10.1097\/PAS.0000000000000322","journal-title":"Am J Surg Pathol"},{"key":"2674_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/PAS.0000000000001789","volume":"46","author":"MJ Hwang","year":"2022","unstructured":"Hwang\u00a0MJ, Hamza\u00a0A, Zhang\u00a0M et\u00a0al (2022) Somatic-type Malignancies in Testicular Germ Cell Tumors: A\u00a0Clinicopathologic Study of 63 Cases. Am J Surg Pathol 46:11\u201317. https:\/\/doi.org\/10.1097\/PAS.0000000000001789","journal-title":"Am J Surg Pathol"},{"key":"2674_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejca.2020.06.008","volume":"136","author":"R Iacovelli","year":"2020","unstructured":"Iacovelli\u00a0R, Ciccarese\u00a0C, Bria\u00a0E et\u00a0al (2020) Patients with sarcomatoid renal cell carcinoma\u2014re-defining the first-line of treatment: A\u00a0meta-analysis of randomised clinical trials with immune checkpoint inhibitors. Eur J Cancer 136:195\u2013203. https:\/\/doi.org\/10.1016\/j.ejca.2020.06.008","journal-title":"Eur J Cancer"},{"key":"2674_CR25","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1097\/PAS.0000000000001354","volume":"43","author":"MT Idrees","year":"2019","unstructured":"Idrees\u00a0MT, Ulbright\u00a0TM, Epstein\u00a0JI (2019) Fluorescent in Situ Hybridization Analysis for 12p Alterations in Sarcomatoid Yolk Sac Tumors. Am J Surg Pathol 43:1566\u20131573. https:\/\/doi.org\/10.1097\/PAS.0000000000001354","journal-title":"Am J Surg Pathol"},{"key":"2674_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2014.12.013","volume":"160","author":"N Irie","year":"2015","unstructured":"Irie\u00a0N, Weinberger\u00a0L, Tang\u00a0WWC et\u00a0al (2015) SOX17 is a\u00a0critical specifier of human primordial germ cell fate. Cell 160:253\u2013268. https:\/\/doi.org\/10.1016\/j.cell.2014.12.013","journal-title":"Cell"},{"key":"2674_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1464-410X.1991.tb15109.x","volume":"67","author":"GM Jeffery","year":"1991","unstructured":"Jeffery\u00a0GM, Theaker\u00a0JM, Lee\u00a0AHS et\u00a0al (1991) The Growing Teratoma Syndrome. Br J Urol 67:195\u2013202. https:\/\/doi.org\/10.1111\/j.1464-410X.1991.tb15109.x","journal-title":"Br J Urol"},{"key":"2674_CR28","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/ijc.32714","volume":"146","author":"SV Jostes","year":"2019","unstructured":"Jostes\u00a0SV, Fellermeyer\u00a0M, Ar\u00e9valo\u00a0L et\u00a0al (2019) Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumour fate. Int J Cancer 146:1592\u20131605. https:\/\/doi.org\/10.1002\/ijc.32714","journal-title":"Int J Cancer"},{"key":"2674_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/BJU.15510","volume":"130","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi\u00a0M, Narita\u00a0S, Matsui\u00a0Y et\u00a0al (2022) Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a\u00a0propensity score matching analysis. BJU Int 130:226\u2013234. https:\/\/doi.org\/10.1111\/BJU.15510","journal-title":"BJU Int"},{"key":"2674_CR30","doi-asserted-by":"publisher","first-page":"eabb6282","DOI":"10.1126\/SCITRANSLMED.ABB6282","volume":"13","author":"FE Kong","year":"2021","unstructured":"Kong\u00a0FE, Li\u00a0GM, Tang\u00a0YQ et\u00a0al (2021) Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Sci Transl Med 13:eabb6282. https:\/\/doi.org\/10.1126\/SCITRANSLMED.ABB6282","journal-title":"Sci Transl Med"},{"key":"2674_CR31","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/IJC.35385","volume":"156","author":"M Kotthoff","year":"2025","unstructured":"Kotthoff\u00a0M, Skowron\u00a0MA, Bremmer\u00a0F et\u00a0al (2025) Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance. Int J Cancer 156:2210\u20132224. https:\/\/doi.org\/10.1002\/IJC.35385","journal-title":"Int J Cancer"},{"key":"2674_CR32","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/BF00185674","volume":"12","author":"JS Little","year":"1994","unstructured":"Little\u00a0JS, Foster\u00a0RS, Ulbright\u00a0TM, Donohue\u00a0JP (1994) Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy. World J Urol 12:200\u2013206. https:\/\/doi.org\/10.1007\/BF00185674","journal-title":"World J Urol"},{"key":"2674_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/HIS.14667","volume":"81","author":"J Lobo","year":"2022","unstructured":"Lobo\u00a0J, Rodrigues \u00c2, Henrique\u00a0R et\u00a0al (2022) Morphological spectrum and molecular features of somatic malignant transformation in germ cell tumours. Histopathology 81:84\u201398. https:\/\/doi.org\/10.1111\/HIS.14667","journal-title":"Histopathology"},{"key":"2674_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/PATH.6412","volume":"266","author":"J Lobo","year":"2025","unstructured":"Lobo\u00a0J, Tavares\u00a0NT, Fonseca\u00a0D et\u00a0al (2025) MicroRNA-371\u2013373 cluster and methylome analysis suggests that a\u00a0subset of \u2018somatic-type\u2019 malignancies arising in germ cell tumors may originate in yolk sac tumor components. J\u00a0Pathol 266:160\u2013176. https:\/\/doi.org\/10.1002\/PATH.6412","journal-title":"J Pathol"},{"key":"2674_CR35","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/1097-0142(19821015)50:83.0.co;2-1","volume":"80","author":"CJ Logothetis","year":"1982","unstructured":"Logothetis\u00a0CJ, Samuels\u00a0ML, Trindade\u00a0A, Johnson\u00a0DE (1982) The growing teratoma syndrome. Cancer 80:1692\u20131935. https:\/\/doi.org\/10.1002\/1097-0142(19821015)50:83.0.co;2-1","journal-title":"Cancer"},{"key":"2674_CR36","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1097\/PAS.0000000000000262","volume":"38","author":"MJ Magers","year":"2014","unstructured":"Magers\u00a0MJ, Kao\u00a0CS, Cole\u00a0CD et\u00a0al (2014) \u201cSomatic-type\u201d malignancies arising from testicular germ cell tumors: A\u00a0Clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin. Am J Surg Pathol 38:1396\u20131409. https:\/\/doi.org\/10.1097\/PAS.0000000000000262","journal-title":"Am J Surg Pathol"},{"key":"2674_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000480830","volume":"32","author":"P Maroto","year":"1997","unstructured":"Maroto\u00a0P, Tabernero\u00a0JM, Villavicencio\u00a0H et\u00a0al (1997) Growing teratoma syndrome: Experience of a\u00a0single institution. Eur Urol 32:305\u2013309. https:\/\/doi.org\/10.1159\/000480830","journal-title":"Eur Urol"},{"key":"2674_CR38","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/J.EURURO.2006.10.021","volume":"51","author":"O El Mesbahi","year":"2007","unstructured":"El Mesbahi\u00a0O, Terrier-Lacombe\u00a0MJ, Rebischung\u00a0C et\u00a0al (2007) Chemotherapy in Patients with Teratoma with Malignant Transformation. Eur Urol 51:1306\u20131312. https:\/\/doi.org\/10.1016\/J.EURURO.2006.10.021","journal-title":"Eur Urol"},{"key":"2674_CR39","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/IJC.28857","volume":"135","author":"P Micke","year":"2014","unstructured":"Micke\u00a0P, Mattsson\u00a0JSM, Edlund\u00a0K et\u00a0al (2014) Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer 135:2206\u20132214. https:\/\/doi.org\/10.1002\/IJC.28857","journal-title":"Int J Cancer"},{"key":"2674_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-5347(01)64035-7","volume":"159","author":"RJ Motzer","year":"1998","unstructured":"Motzer\u00a0RJ, Amsterdam\u00a0A, Prieto\u00a0V et\u00a0al (1998) Teratoma with malignant transformation: Diverse malignant histologies arising in men with germ cell tumors. J\u00a0Urol 159:133\u2013138. https:\/\/doi.org\/10.1016\/S0022-5347(01)64035-7","journal-title":"J Urol"},{"key":"2674_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2605.2011.01172.x","volume":"34","author":"D Nettersheim","year":"2011","unstructured":"Nettersheim\u00a0D, Gillis\u00a0AJM, Looijenga\u00a0LHJ, Schorle\u00a0H (2011) TGF-\u03b21, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam\u20112 into a\u00a0cell type resembling mixed non-seminoma. Int J Androl 34:189\u2013203. https:\/\/doi.org\/10.1111\/j.1365-2605.2011.01172.x","journal-title":"Int J Androl"},{"key":"2674_CR42","doi-asserted-by":"publisher","first-page":"47095","DOI":"10.18632\/oncotarget.9903","volume":"7","author":"D Nettersheim","year":"2016","unstructured":"Nettersheim\u00a0D, Heimsoeth\u00a0A, Jostes\u00a0S et\u00a0al (2016) SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2\u00a0cells to an embryonal carcinoma-like fate. Oncotarget 7:47095\u201347110. https:\/\/doi.org\/10.18632\/oncotarget.9903","journal-title":"Oncotarget"},{"key":"2674_CR43","doi-asserted-by":"publisher","first-page":"e1005415","DOI":"10.1371\/journal.pgen.1005415","volume":"11","author":"D Nettersheim","year":"2015","unstructured":"Nettersheim\u00a0D, Jostes\u00a0S, Sharma\u00a0R et\u00a0al (2015) BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma. PLoS Genet 11:e1005415. https:\/\/doi.org\/10.1371\/journal.pgen.1005415","journal-title":"PLoS Genet"},{"key":"2674_CR44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cancers11050728","volume":"11","author":"D Nettersheim","year":"2019","unstructured":"Nettersheim\u00a0D, Vadder\u00a0S, Jostes\u00a0S et\u00a0al (2019) TCam-2\u00a0cells deficient for SOX2 and FOXA2 are blocked in differentiation and maintain a\u00a0seminoma-like cell fate in vivo. Cancers 11:728. https:\/\/doi.org\/10.3390\/cancers11050728","journal-title":"Cancers"},{"key":"2674_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1309\/AJCP7MNCNBCRN8NO","volume":"131","author":"D Nonaka","year":"2009","unstructured":"Nonaka\u00a0D (2009) Differential Expression of SOX2 and SOX17 in Testicular Germ Cell Tumors. Am J Clin Pathol 131:731\u2013736. https:\/\/doi.org\/10.1309\/AJCP7MNCNBCRN8NO","journal-title":"Am J Clin Pathol"},{"key":"2674_CR46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41568-019-0178-9","volume":"19","author":"JW Oosterhuis","year":"2019","unstructured":"Oosterhuis\u00a0JW, Looijenga\u00a0LHJ (2019) Human germ cell tumours from a\u00a0developmental perspective. Nat Rev Cancer 19:522\u2013537. https:\/\/doi.org\/10.1038\/s41568-019-0178-9","journal-title":"Nat Rev Cancer"},{"key":"2674_CR47","doi-asserted-by":"publisher","first-page":"529.e23","DOI":"10.1016\/J.UROLONC.2018.09.012","volume":"36","author":"P Paffenholz","year":"2018","unstructured":"Paffenholz\u00a0P, Pfister\u00a0D, Matveev\u00a0V, Heidenreich\u00a0A (2018) Diagnosis and management of the growing teratoma syndrome: A\u00a0single-center experience and review of the literature. Urol Oncol 36:529.e23\u2013529.e30. https:\/\/doi.org\/10.1016\/J.UROLONC.2018.09.012","journal-title":"Urol Oncol"},{"key":"2674_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/J.CANLET.2024.216673","author":"P Pongratanakul","year":"2024","unstructured":"Pongratanakul\u00a0P, Bremmer\u00a0F, Pauls\u00a0S et\u00a0al (2024) Assessing the risk to develop a\u00a0growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers. Cancer Lett. https:\/\/doi.org\/10.1016\/J.CANLET.2024.216673","journal-title":"Cancer Lett"},{"key":"2674_CR49","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1126\/SCIENCE.AAY5967","volume":"367","author":"K Reinhard","year":"2020","unstructured":"Reinhard\u00a0K, Rengstl\u00a0B, Oehm\u00a0P et\u00a0al (2020) An RNA vaccine drives expansion and efficacy of claudin-CAR-T\u00a0cells against solid tumors. Science 367:446\u2013453. https:\/\/doi.org\/10.1126\/SCIENCE.AAY5967","journal-title":"Science"},{"key":"2674_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/HIS.15277","volume":"85","author":"C Ricci","year":"2024","unstructured":"Ricci\u00a0C, Ambrosi\u00a0F, Grillini\u00a0A et\u00a0al (2024) Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and \u2018somatic-type\u2019 adenocarcinoma. Histopathology 85:695\u2013698. https:\/\/doi.org\/10.1111\/HIS.15277","journal-title":"Histopathology"},{"key":"2674_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/S00428-023-03725-0","volume":"484","author":"C Ricci","year":"2024","unstructured":"Ricci\u00a0C, Ambrosi\u00a0F, Grillini\u00a0A et\u00a0al (2024) Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a\u00a0mature yolk sac tumor phenotype may underlie sarcomatoid transformation. Virchows Arch 484:709\u2013713. https:\/\/doi.org\/10.1007\/S00428-023-03725-0","journal-title":"Virchows Arch"},{"key":"2674_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/S00428-025-04062-0","author":"C Ricci","year":"2025","unstructured":"Ricci\u00a0C, Melotti\u00a0S, Di Sciascio\u00a0L et\u00a0al (2025) Analysis of HNF1\u03b2 expression suggests that its downregulation is involved in the sarcomatoid transformation of yolk sac tumor. Virchows Arch. https:\/\/doi.org\/10.1007\/S00428-025-04062-0","journal-title":"Virchows Arch"},{"key":"2674_CR53","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.juro.2014.05.118","volume":"192","author":"KR Rice","year":"2014","unstructured":"Rice\u00a0KR, Magers\u00a0MJ, Beck\u00a0SDW et\u00a0al (2014) Management of germ cell tumors with somatic type malignancy: Pathological features, prognostic factors and survival outcomes. J\u00a0Urol 192:1403\u20131409. https:\/\/doi.org\/10.1016\/j.juro.2014.05.118","journal-title":"J Urol"},{"key":"2674_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/S00428-024-03911-8","author":"L Di Sciascio","year":"2024","unstructured":"Di Sciascio\u00a0L, Orsatti\u00a0A, Ambrosi\u00a0F et\u00a0al (2024) Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a\u00a0broad immunohistochemical panel. Virchows Arch. https:\/\/doi.org\/10.1007\/S00428-024-03911-8","journal-title":"Virchows Arch"},{"key":"2674_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.PATH.2024.08.010","volume":"18","author":"SE Siegmund","year":"2025","unstructured":"Siegmund\u00a0SE, Acosta\u00a0AM (2025) Somatic-type Malignancies of Germ Cell Origin: Molecular, Pathologic, and Clinical Features. Surg Pathol Clin 18:101\u2013117. https:\/\/doi.org\/10.1016\/J.PATH.2024.08.010","journal-title":"Surg Pathol Clin"},{"key":"2674_CR56","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/JAMA.2024.27122","volume":"333","author":"N Singla","year":"2025","unstructured":"Singla\u00a0N, Bagrodia\u00a0A, Baraban\u00a0E et\u00a0al (2025) Testicular Germ Cell Tumors: A\u00a0Review. JAMA 333:793\u2013803. https:\/\/doi.org\/10.1001\/JAMA.2024.27122","journal-title":"JAMA"},{"key":"2674_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/S10020-023-00636-3","volume":"29","author":"MA Skowron","year":"2023","unstructured":"Skowron\u00a0MA, Kotthoff\u00a0M, Bremmer\u00a0F et\u00a0al (2023) Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options. Mol Med 29:40. https:\/\/doi.org\/10.1186\/S10020-023-00636-3","journal-title":"Mol Med"},{"key":"2674_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/J.CANLET.2021.07.037","volume":"519","author":"MA Skowron","year":"2021","unstructured":"Skowron\u00a0MA, Oing\u00a0C, Bremmer\u00a0F et\u00a0al (2021) The developmental origin of cancers defines basic principles of cisplatin resistance. Cancer Lett 519:199\u2013210. https:\/\/doi.org\/10.1016\/J.CANLET.2021.07.037","journal-title":"Cancer Lett"},{"key":"2674_CR59","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/S-0044-1788307","volume":"46","author":"P Subramanian","year":"2024","unstructured":"Subramanian\u00a0P, Arora\u00a0A, Pal\u00a0M et\u00a0al (2024) Spectrum of Somatic Malignancy in Testicular Germ Cell Tumors\u2014A Histopathological Review of 25 Cases with Clinical Outcome. Indian J Med Paediatr Oncol 46:174\u2013182. https:\/\/doi.org\/10.1055\/S-0044-1788307","journal-title":"Indian J Med Paediatr Oncol"},{"key":"2674_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/NATURE20596","volume":"540","author":"A Taylor-Weiner","year":"2016","unstructured":"Taylor-Weiner\u00a0A, Zack\u00a0T, O\u2019Donnell\u00a0E et\u00a0al (2016) Genomic evolution and chemoresistance in germ-cell tumours. Nature 540:114\u2013118. https:\/\/doi.org\/10.1038\/NATURE20596","journal-title":"Nature"},{"key":"2674_CR61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1200\/JCO.23.01099","volume":"42","author":"LB Travis","year":"2024","unstructured":"Travis\u00a0LB, Feldman\u00a0DR, Fung\u00a0C et\u00a0al (2024) Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship. JCO 42:696\u2013706. https:\/\/doi.org\/10.1200\/JCO.23.01099","journal-title":"JCO"},{"key":"2674_CR62","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/S40164-023-00460-9","volume":"12","author":"GA Wakileh","year":"2023","unstructured":"Wakileh\u00a0GA, Bierholz\u00a0P, Kotthoff\u00a0M et\u00a0al (2023) Molecular characterization of the CXCR4 \/ CXCR7 axis in germ cell tumors and its targetability using nanobody-drug-conjugates. Exp Hematol Oncol 12:96. https:\/\/doi.org\/10.1186\/S40164-023-00460-9","journal-title":"Exp Hematol Oncol"},{"key":"2674_CR63","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/PAS.0000000000002241","volume":"48","author":"RD Whaley","year":"2024","unstructured":"Whaley\u00a0RD, Ulbright\u00a0TM (2024) Primitive Embryonic-Type Neuroectodermal\/Glandular Complexes in Testicular Germ Cell Tumors: A\u00a0Mimic of Embryonic-Type Neuroectodermal Tumor. Am J Surg Pathol 48:909\u2013917. https:\/\/doi.org\/10.1097\/PAS.0000000000002241","journal-title":"Am J Surg Pathol"},{"key":"2674_CR64","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/jcmm.16222","volume":"25","author":"W Wruck","year":"2021","unstructured":"Wruck\u00a0W, Bremmer\u00a0F, Kotthoff\u00a0M et\u00a0al (2021) The pioneer and differentiation factor FOXA2 is a\u00a0key driver of yolk-sac tumour formation and a\u00a0new biomarker for paediatric and adult yolk-sac tumours. J\u00a0Cell Mol Med 25:1394\u20131405. https:\/\/doi.org\/10.1111\/jcmm.16222","journal-title":"J Cell Mol Med"},{"key":"2674_CR65","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/S41379-022-01136-1","volume":"35","author":"N Wyvekens","year":"2022","unstructured":"Wyvekens\u00a0N, Sholl\u00a0LM, Yang\u00a0Y et\u00a0al (2022) Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies. Mod Pathol 35:1966\u20131973. https:\/\/doi.org\/10.1038\/S41379-022-01136-1","journal-title":"Mod Pathol"},{"key":"2674_CR66","doi-asserted-by":"publisher","first-page":"100702","DOI":"10.1016\/J.MODPAT.2024.100702","volume":"38","author":"Y Zong","year":"2025","unstructured":"Zong\u00a0Y, Huang\u00a0R, Bitar\u00a0M et\u00a0al (2025) Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell Tumors. Mod Pathol 38:100702. https:\/\/doi.org\/10.1016\/J.MODPAT.2024.100702","journal-title":"Mod Pathol"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02674-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02674-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:29:51Z","timestamp":1759386591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02674-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02674-7","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"type":"print","value":"2731-7064"},{"type":"electronic","value":"2731-7072"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"12 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.A.\u00a0Skowron, L.\u00a0Schneider, E.\u00a0Prokakis, A.\u00a0Fichtner, T.\u00a0Nestler, F.\u00a0Bremmer und D.\u00a0Nettersheim geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}